Loading...
Keywords
Last Name
Institution

Search Results (15)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Clinical Trials, Phase I as TopicConcept Why?
Clinical Trials, Phase II as TopicConcept Why?
Clinical Trials, Phase III as TopicConcept Why?
Clinical Trials, Phase IV as TopicConcept Why?
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls.Academic Article Why?
Ginn, KevinPerson Why?
Gamis, AlanPerson Why?
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.Academic Article Why?
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.Academic Article Why?
Abdel-Rahman, SusanPerson Why?
Guest, ErinPerson Why?
Truog, WilliamPerson Why?
Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group.Academic Article Why?
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.Academic Article Why?
Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.Academic Article Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • Clinical Trials Phase 1
Filter by Type